Kaya17, a privately held business funded by investors, was established in 2015 with the primary objective of reducing the time between testing, diagnosis and treatment. Also, based on personal experience, it was critical to us to be able to test when and where needed rather than in specialized facilities.
Building upon our success in identifying food pathogens in produce (fruits and vegetables), we have updated the design of the various components to be able to identify bacteria, virus, pollen and other protein-based pathogens in small specimen samples with very high sensitivity.
Currently, we are focusing on adapting our technology for the quick and timely diagnosis of the SARS-CoV-2 virus, which has caused the largest pandemic in recent history.
Su has a PhD in Molecular Biology from New York University
She has over 20 years of experience in Product Innovation, Development and Strategy at Roche Diagnostics, Thermo Fisher Scientific, and Bayer Diagnostics.
She was the Founder and Chief Scientific Officer of Nano Science Diagnostics, a Point of Care focused company.
Sri has a PhD in Electrical Engineering from Columbia University
He has more than 25 years of experience in Analog chip design electronic systems, medical devices, and Artificial Intelligence based systems.
He was the Founder and CEO of Free Electron Technology, a 10 Gbps Communications Chip company.
Camille received her PhD in Molecular Biology from University of California at San Francisco
She has over 25 years of experience developing and commercializing biomolecular assays and platforms.
Anup brings more than 20 years of experience in delivering innovative solutions to support multiple aspects of clinical trials.
He co-founded Duramed Pharmaceuticals which went public, Trinity Laboratories, which was acquired, and a mail order prescription drug company, Medi Rx America, which went public. He has worked as Managing Director at Peregrine Capital Ltd. in Hong Kong for four years during 1993-1997. During his years as a practicing attorney in New York, he has represented the Governments of Indonesia and Sweden in certain commercial matters, and has handled several IPOs of successful early stage enterprises
Prominent member and Physician Advisor to the COVID Response Task Force / Command Center St. Rose Hospital
Experienced medical device developer and entrepreneur with over 30 years in the industry.
In 2010, Mr. Levinson co-founded Cerebrotech Medical Systems, Inc..
Previously CEO of Zeltiq Aesthetics, Inc. (Coolsculpting, ZLTQ) and VP of Thermage, Inc. (later renamed Solta Medical, SLTA). Levinson also sits on the Board of Directors of Pulse Biosciences (PLSE) and ConnectWell.